• Citer

Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients

par Awada, Gil;de Azambuja, Evandro ;Awada, Ahmad
Référence Expert Opinion on Drug Metabolism & Toxicology, 13, 12, page (1205-1215)
Publication Publié, 2017-12

Article révisé par les pairs

• Détails
• Contenu

Titre:	Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients
Auteur:	Awada, Gil; de Azambuja, Evandro; Awada, Ahmad
Informations sur la publication:	Expert Opinion on Drug Metabolism & Toxicology, 13, 12, page (1205-1215)
Statut de publication:	Publié, 2017-12
Sujet CREF:	Pharmacologie
	Toxicologie pharmaceutique
Mots-clés:	angiotensin converting enzyme inhibitor
	angiotensin receptor blocker
	beta blocker
	Cancer
	left ventricular dysfunction
	prevention
	targeted therapy
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:1742-5255
	info:doi/10.1080/17425255.2017.1398733
	info:scp/85036572611
	info:pmid/29088977